Patents by Inventor Leonard I. Wiebe

Leonard I. Wiebe has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20020025296
    Abstract: A method and use of a labelled compound for monitoring the transfer of a foreign gene including selecting the foreign gene which has been isolated from a cell or virus and transferred into a cell population and selecting the labelled compound which will interact selectively with a protein expressed by the foreign gene to produce a labelled product. The labelled compound has a rate of expulsion from the cells which is greater than that of the labelled product. Further, the use and method include administering to the cells an effective dose of the labelled compound such that the labelled compound selectively interacts with the protein to produce the labelled product, waiting a period of time such that a substantial amount of the labelled compound has been expelled from the cells and such that a detectable amount of the labelled product remains and determining the extent and location of the protein by detecting the labelled product.
    Type: Application
    Filed: May 14, 2001
    Publication date: February 28, 2002
    Inventors: Edward E. Knaus, Leonard I. Wiebe, Kevin Morin
  • Patent number: 5739121
    Abstract: Novel fluorine-containing cyclic saccharide compounds, in particular fluorocyclodextrin compounds, and drug inclusion complexes of these compounds, as well as methods for preparation of the novel fluorine-containing cyclic saccharide compounds, including fluorocyclodextrins, and drug inclusion complexes of the compounds. In addition, methods for following the disposition and fate in vivo of drug inclusion complexes of the invention.
    Type: Grant
    Filed: December 12, 1994
    Date of Patent: April 14, 1998
    Assignee: University of Alberta
    Inventors: Leonard I. Wiebe, James Diakur
  • Patent number: 5401490
    Abstract: Novel nucleosides are provided having at least one hydrogen or hydroxide substitutent replaced by a .gamma.-emitting halogen. Methods of preparation of these nucleosides are provided and also a novel non-invasive method for the detection and measurement of tissue hypoxia in mammals.
    Type: Grant
    Filed: November 19, 1992
    Date of Patent: March 28, 1995
    Assignee: Alberta Cancer Board
    Inventors: Leonard I. Wiebe, John R. Mercer, John D. Chapman, Rezaul H. Mannan, Vijayalakashmi Somayaji
  • Patent number: 4430321
    Abstract: Novel 6-bromo derivatives of cholesterol have the formula ##STR1## Such compounds are prepared from the known 6-iodocholesterol by treatment with cuprous bromide.These compounds, labelled with radioisotopes of Br-82 or Br-77, are localized in the adrenal, mammary and ovary tissue of female mammals and in the adrenal or prostate tissue of males when administered to such individuals. This provides a method for imaging adrenal, ovary or prostate tissue which is superior to use of the prior art 6-iodo-cholesterol.
    Type: Grant
    Filed: January 15, 1982
    Date of Patent: February 7, 1984
    Assignee: Merck Frosst Canada Inc.
    Inventors: Richard J. Flanagan, Leonard I. Wiebe